期刊文献+

血清多项指标联合检测对乳腺癌的鉴别诊断和预后评估作用 被引量:6

Role of serum multi-index combined detection in differential diagnosis and prognosis evaluation of breast cancer
原文传递
导出
摘要 目的:血清肿瘤抗原153(CA153)、糖类抗原125(CA125)、癌胚抗原(CEA)、降钙素和铁蛋白等指标联合检测对乳腺癌的鉴别诊断和预后评估作用。方法:对2016-06-2018-06就诊的250例女性患者进行研究,根据研究对象健康状态与确诊疾病分为正常组、乳腺炎组、乳腺增生组、乳腺纤维瘤组、乳腺癌组,每组50例。检查5组患者年龄、乳房疾病史、文化程度、病理分期指标的差异和血清中的CA125、CA153、CEA、铁蛋白、降钙素,观察并比较这5项肿瘤标志物对5组患者中表达含量的统计学差异,应用回归分析方法分析各肿瘤标记物对乳腺癌患者疾病复发或疾病转移的综合影响。结果:5组患者年龄、乳房疾病史、文化程度、病理分期指标的差异无统计学意义(P>0.05);通过对5组患者多项血清生化指标含量的比较,发现CA125、CA153、铁蛋白指标的差异有统计学意义(P<0.05);由血清多项生化指标联合检测对乳腺癌组患者疾病复发和转移的评估作用可以看出,乳腺癌患者复发情况CA125、CA153、铁蛋白指标的差异有统计学意义(P<0.05);转移情况患者CA125、CA153、CEA、铁蛋白指标的差异有统计学意义(P<0.05)。结论:CA125、CA153、CEA、铁蛋白、降钙素联合检测可以提高对乳腺癌的鉴别诊断和预后评估的特异性和敏感性。 Objective:To investigate the role of combined detection of serum tumor antigen 153(CA153),carbohydrate antigen 125(CA125),carcinoembryonic antigen(CEA),calcitonin and ferritin indicators in the differential diagnosis and prognosis evaluation of breast cancer. Method:From June 2016 to June 2018,250 women admitted to Shaoguan First People’s Hospital were divided into normal group,mastitis group,mammary gland hyperplasia group,mammary fibroids group and breast cancer group according to their health status and diagnosed diseases,with 50 cases in each group.Check the five group objects Age,breast disease history,education level,the pathological staging index and serum levels of CA125,CA153,CEA,ferritin and calcitonin of all patients were collected,the expression levels of the five tumor markers were compared,and the comprehensive effect of each tumor marker on breast cancer disease recurrence or metastasis was analyzed using regression analysis. Result:There was no statistically significant difference in age,breast disease history,education level and pathological staging of the five groups(P>0.05).By comparing the contents of multiple serum biochemical indexes in the five groups,the differences of CA125,CA153 and ferritin in the five groups were statistically significant(P<0.05).By multiple serum biochemical indexes combined detection of disease recurrence and metastasis in patients with breast cancer group,it can be seen that the differences of recurrence indexes CA125,CA153 and ferritin in patients with breast cancer were statistically significant(P<0.05).The differences of CA125,CA153,CEA and ferritin in metastatic patients were statistically significant(P<0.05).Conclusion:Combined detection of CA125,CA153,CEA,ferritin and calcitonin could improve the specificity and sensitivity of differential diagnosis and prognosis evaluation of breast cancer.
作者 赖玉玲 黄丽芳 许晓峰 LAI Yuling;HUANG Lifang;XU Xiaofeng(Department of Clinical Laboratory,Shaoguan First People's Hospital,Shaoguan,512000,China;Department of Oncology,Shaoguan First People's Hospital)
出处 《临床血液学杂志(输血与检验)》 CAS 2019年第6期922-926,共5页 Journal of Clinical Hematology(Blood Transfusion & Laboratory Medicine)
关键词 乳腺癌 肿瘤标志物 联合检测 breast cancer tumor markers combined detection
  • 相关文献

参考文献6

二级参考文献39

共引文献96

同被引文献69

引证文献6

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部